BioWorld MedTech

Nov. 15, 2013

Svelte enrolls final patient in DIRECT II clinical study

Svelte Medical Systems (New Providence, New Jersey) reported the enrollment of the final patient in the DIRECT II (Direct Implantation of Rapamycin-Eluting stents with bioabsorbable drug Carrier Technology) clinical study. Read More

Chinese orthopedic company initiates IPO in Hong Kong

International report: AirXpanders gets Australian approval for its AeroForm

Washington roundup: FDA approves NeuroPace RNS for refractory epilepsy

Court report: J&J looking at $4 billion settlement regarding ASR

Financings roundup: Tandem Diabetes Care prices IPO at $15/share

Patent watch: Neovasc gets protection for Tiara valve prosthesis

Agreements/contracts: Visualant and IV to accelerate ChromaID tech applications

Deals roundup: PositiveID sells interest in VeriTeQ for $750,000

People in the News

Product Briefs

Med-Tech Notes

MDD's Diagnostic Extra

Today's news in brief

BioWorld

Illustration of SCAN in Parkinson’s vs healthy subcortex

SCAN is core circuit affected in Parkinson’s disease

BioWorld Science

Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...

TL1A is overexpressed in hidradenitis suppurativa

BioWorld Science

Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...

IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

BioWorld Science

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...

Illustration of head with maze that is missing parts

Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

BioWorld Science

Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...